Cargando…
Wnt pathway is involved in 5-FU drug resistance of colorectal cancer cells
Colorectal cancer (CRC) is one of the leading causes of cancer-related death worldwide. 5-Fluorouracil (5-FU) is widely used in the treatment of cancers, but its antineoplastic activity is limited in drug-resistant cancer cells. To investigate the detailed mechanism of 5-FU resistance, we developed...
Autores principales: | He, Lingfeng, Zhu, Hong, Zhou, Shiying, Wu, Ting, Wu, Huan, Yang, Huan, Mao, Huiwen, SekharKathera, Chandra, Janardhan, Avilala, Edick, Ashlin M., Zhang, Anna, Hu, Zhigang, Pan, Feiyan, Guo, Zhigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6093888/ https://www.ncbi.nlm.nih.gov/pubmed/30111797 http://dx.doi.org/10.1038/s12276-018-0128-8 |
Ejemplares similares
-
Prominent role of histone lysine demethylases in cancer epigenetics and therapy
por: Janardhan, Avilala, et al.
Publicado: (2018) -
Interacting partners of FEN1 and its role in the development of anticancer therapeutics
por: Kathera, Chandrasekhar, et al.
Publicado: (2017) -
FEN1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer
por: He, Lingfeng, et al.
Publicado: (2017) -
FEN1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer
por: He, Lingfeng, et al.
Publicado: (2017) -
Targeting DNA Flap Endonuclease 1 to Impede Breast Cancer Progression
por: He, Lingfeng, et al.
Publicado: (2016)